tiprankstipranks
Advertisement
Advertisement

ANIK Stock Latest News

Anika Therapeutics Earnings Call Signals Cautious Rebound
Company AnnouncementsAnika Therapeutics Earnings Call Signals Cautious Rebound
27d ago
ANIK
Anika Therapeutics price target raised to $17 from $16 at Barrington
PremiumThe Fly
Anika Therapeutics price target raised to $17 from $16 at Barrington
1M ago
ANIK
Anika Therapeutics price target raised to $18 from $16 at B. Riley
PremiumThe Fly
Anika Therapeutics price target raised to $18 from $16 at B. Riley
1M ago
ANIK
Anika Announces Executive Transition Amid Stable Quarterly Results
PremiumCompany Announcements
Anika Announces Executive Transition Amid Stable Quarterly Results
1M ago
8K
ANIK
Anika Therapeutics reports Q4 EPS 31c vs (3c) last year
PremiumThe Fly
Anika Therapeutics reports Q4 EPS 31c vs (3c) last year
1M ago
ANIK
Anika Therapeutics sees FY26 revenue $114M-$122.5M
PremiumThe FlyAnika Therapeutics sees FY26 revenue $114M-$122.5M
1M ago
ANIK
ANIK Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANIK Upcoming Earnings Report: What to Expect?
1M ago
ANIK
Anika Therapeutics Announces CEO Transition and Governance Changes
Premium
Company Announcements
Anika Therapeutics Announces CEO Transition and Governance Changes
3M ago
8K
ANIK
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
PremiumThe Fly
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
3M ago
ANIK
Anika Therapeutics price target raised to $16 from $15 at Barrington
PremiumThe Fly
Anika Therapeutics price target raised to $16 from $15 at Barrington
5M ago
ANIK
Anika Therapeutics Reports Mixed Q3 2025 Results
PremiumCompany Announcements
Anika Therapeutics Reports Mixed Q3 2025 Results
5M ago
ANIK
Anika Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Anika Therapeutics’ Earnings Call: Growth Amid Challenges
5M ago
ANIK
Anika Therapeutics Files Final Module for Hyalofast
PremiumCompany AnnouncementsAnika Therapeutics Files Final Module for Hyalofast
5M ago
8K
ANIK
Anika reports filing of final PMA module for Hylofast cartilage repair
Premium
The Fly
Anika reports filing of final PMA module for Hylofast cartilage repair
5M ago
ANIK
Anika Therapeutics reaffirms FY25 guidance
Premium
The Fly
Anika Therapeutics reaffirms FY25 guidance
5M ago
ANIK
Anika Therapeutics commences $15M 10b5-1 share repurchase
PremiumThe Fly
Anika Therapeutics commences $15M 10b5-1 share repurchase
5M ago
ANIK
Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year
PremiumThe Fly
Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year
5M ago
ANIK
Is ANIK a Buy, Before Earnings?
PremiumPre-Earnings
Is ANIK a Buy, Before Earnings?
5M ago
ANIK
Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer?
PremiumCompany Announcements
Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer?
5M ago
ANIK
Anika Therapeutics: Undervalued Stock with Potential Upside Amidst Execution Challenges
PremiumRatingsAnika Therapeutics: Undervalued Stock with Potential Upside Amidst Execution Challenges
6M ago
ANIK
Anika Therapeutics price target lowered to $15 from $19 at Barrington
Premium
The Fly
Anika Therapeutics price target lowered to $15 from $19 at Barrington
8M ago
ANIK
Anika Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Anika Therapeutics Reports Q2 2025 Financial Results
8M ago
ANIK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >